67 related articles for article (PubMed ID: 9764793)
1. Highly active antiretroviral therapy leads to a significant but delayed increase of CD45RA+ T-helper cells.
Degen O; Stellbrink HJ; Lauer J; van Lunzen J
AIDS; 1998 Sep; 12(13):1715-6. PubMed ID: 9764793
[No Abstract] [Full Text] [Related]
2. Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection.
Sousa AE; Chaves AF; Doroana M; Antunes F; Victorino RM
J Immunol; 1999 Mar; 162(6):3718-26. PubMed ID: 10092835
[TBL] [Abstract][Full Text] [Related]
3. Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment.
David D; Naït-Ighil L; Dupont B; Maral J; Gachot B; Thèze J
J Infect Dis; 2001 Mar; 183(5):730-5. PubMed ID: 11181149
[TBL] [Abstract][Full Text] [Related]
4. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.
Kou ZC; Puhr JS; Wu SS; Goodenow MM; Sleasman JW
J Infect Dis; 2003 Feb; 187(3):385-97. PubMed ID: 12552422
[TBL] [Abstract][Full Text] [Related]
5. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
Seth A; Markee J; Hoering A; Sevin A; Sabath DE; Schmitz JE; Kuroda MJ; Lifton MA; Hirsch MS; Collier AC; Letvin NL; McElrath MJ
J Infect Dis; 2001 Mar; 183(5):722-9. PubMed ID: 11181148
[TBL] [Abstract][Full Text] [Related]
6. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
Choremi-Papadopoulou H; Tsalimalma K; Dafni U; Dimitracopoulou A; Kordossis T
J Med Virol; 2004 Jun; 73(2):235-43. PubMed ID: 15122798
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
8. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
[TBL] [Abstract][Full Text] [Related]
9. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
Jankelevich S; Mueller BU; Mackall CL; Smith S; Zwerski S; Wood LV; Zeichner SL; Serchuck L; Steinberg SM; Nelson RP; Sleasman JW; Nguyen BY; Pizzo PA; Yarchoan R
J Infect Dis; 2001 Apr; 183(7):1116-20. PubMed ID: 11237839
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
11. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
[No Abstract] [Full Text] [Related]
12. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
13. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
15. HIV therapeutics: points from the recent literature.
Laurence J
AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
[No Abstract] [Full Text] [Related]
16. Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies.
Tebas P; Henry K; Mondy K; Deeks S; Valdez H; Cohen C; Powderly WG
J Infect Dis; 2002 Sep; 186(6):851-4. PubMed ID: 12198623
[TBL] [Abstract][Full Text] [Related]
17. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.
Haslett PA; Nixon DF; Shen Z; Larsson M; Cox WI; Manandhar R; Donahoe SM; Kaplan G
J Infect Dis; 2000 Apr; 181(4):1264-72. PubMed ID: 10751137
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
[TBL] [Abstract][Full Text] [Related]
19. Can the body control HIV infection without drugs?
Check E
Newsweek; 2000 Oct; 136(15):59. PubMed ID: 11184537
[No Abstract] [Full Text] [Related]
20. A model predictive control based scheduling method for HIV therapy.
Zurakowski R; Teel AR
J Theor Biol; 2006 Jan; 238(2):368-82. PubMed ID: 15993900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
